enGene Therapeutics

ENGN

enGene Therapeutics has been a target of short sellers for a while. The current short interest of 2.42% is roughly at the average of the last 12 months (2.14%).

Short Interest Trend

Share Price

Total NSP

2.42%

+0.18%

vs. last month

Also interesting? All insider buys at enGene Therapeutics

Found an error? Questions? Ideas?